Glenmark Pharmaceuticals has provided details of its Key Managerial Personnel authorized to determine the materiality of events and make disclosures to stock exchanges, including contacts for Mr. Glenn Saldanha (Chairman), Mrs. Cherylann Pinto, Mr. Anurag Mantri, and Mr. Harish Kuber.